{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:55:41Z","timestamp":1792151741904,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BAMSHA18XX0"],"award-info":[{"award-number":["BAMSHA18XX0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CUTTIN18XX1"],"award-info":[{"award-number":["CUTTIN18XX1"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["KNOWLE18XX0"],"award-info":[{"award-number":["KNOWLE18XX0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jcf.2023.05.004","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T15:30:21Z","timestamp":1684596621000},"page":"857-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-614X","authenticated-orcid":false,"given":"Margaret","family":"Rosenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-9548","authenticated-orcid":false,"given":"Anna V.","family":"Faino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankline M.","family":"Onchiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0633-0305","authenticated-orcid":false,"given":"Elizabeth E.","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Collaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1334-4235","authenticated-orcid":false,"given":"William W.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Szczesniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0861","authenticated-orcid":false,"given":"Michael J.","family":"Bamshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.05.004_bib0001","series-title":"Cystic fibrosis foundation patient registry 2020 annual data report","year":"2020"},{"issue":"10","key":"10.1016\/j.jcf.2023.05.004_bib0002","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thoraxjnl-2011-200953","article-title":"Understanding the natural progression in%FEV1 decline in patients with cystic fibrosis: a longitudinal study","volume":"67","author":"Taylor-Robinson","year":"2012","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jcf.2023.05.004_bib0003","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jcf.2017.10.008","article-title":"Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis","volume":"17","author":"Heltshe","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2023.05.004_bib0004","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic fibrosis foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.jcf.2023.05.004_bib0005","article-title":"Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis","volume":"12","author":"Palser","year":"2019","journal-title":"Cochrane Libr Cochrane Rev"},{"issue":"1","key":"10.1016\/j.jcf.2023.05.004_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"Suppl 2","key":"10.1016\/j.jcf.2023.05.004_bib0007","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S1569-1993(11)60011-8","article-title":"Chronic Pseudomonas aeruginosa infection definition: euroCareCF working group report","volume":"10","author":"Pressler","year":"2011","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"1","key":"10.1016\/j.jcf.2023.05.004_bib0008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ppul.23036","article-title":"Clinical outcomes after initial Pseudomonas acquisition in cystic fibrosis","volume":"50","author":"Zemanick","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2023.05.004_bib0009","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2007.03.006","article-title":"Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis","volume":"151","author":"Konstan","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.jcf.2023.05.004_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00166412","article-title":"Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry","volume":"43","author":"Kerem","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.05.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2022.04.013","article-title":"Early Pseudomonas aeruginosa predicts poorer pulmonary function in preschool children with cystic fibrosis","author":"Aurora","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2023.05.004_bib0012","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ppul.21397","article-title":"Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease","volume":"46","author":"Pittman","year":"2011","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2023.05.004_bib0013","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jcf.2017.01.002","article-title":"Use of FEV(1) in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher","volume":"16","author":"Szczesniak","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.05.004_bib0014","series-title":"Cystic fibrosis foundation patient registry 2020 annual data report","year":"2020"},{"issue":"1","key":"10.1016\/j.jcf.2023.05.004_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcf.2021.07.020","article-title":"Comparing encounter-based and annualized chronic pseudomonas infection definitions in cystic fibrosis","volume":"21","author":"Rosenfeld","year":"2022","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"issue":"2","key":"10.1016\/j.jcf.2023.05.004_bib0016","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpeds.2012.01.042","article-title":"Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis","volume":"161","author":"Green","year":"2012","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jcf.2023.05.004_bib0017","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1164\/rccm.201404-0681OC","article-title":"Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes","volume":"190","author":"Mayer-Hamblett","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.jcf.2023.05.004_bib0018","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ng.2344","article-title":"Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"44","author":"Emond","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.jcf.2023.05.004_bib0019","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2023.05.004_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1465-9921-11-140","article-title":"Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients","volume":"11","author":"Green","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2023.05.004_bib0021","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201404-0681OC","article-title":"Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes","author":"Mayer-Hamblett","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2023.05.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106103","article-title":"A comparison of the CFHH criteria against the Leeds criteria in determining the Pseudomonas aeruginosa status among adults with cystic fibrosis","volume":"171","author":"Hoo","year":"2020","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.jcf.2023.05.004_bib0023","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2023.05.004_bib0024","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/thoraxjnl-2021-216849","article-title":"Lung function in children with cystic fibrosis in the USA and UK: a comparative longitudinal analysis of national registry data","volume":"77","author":"Schl\u00fcter","year":"2022","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jcf.2023.05.004_bib0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12931-019-1068-0","article-title":"Distinctive lung function trajectories from age 10 to 26\u2009years in men and women and associated early life risk factors - a birth cohort study","volume":"20","author":"Karmaus","year":"2019","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.jcf.2023.05.004_bib0026","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ppul.23217","article-title":"Risk factors for lung function decline in a large cohort of young cystic fibrosis patients","volume":"50","author":"Cogen","year":"2015","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"10.1016\/j.jcf.2023.05.004_bib0027","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V","article-title":"Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis","volume":"28","author":"Rosenfeld","year":"1999","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.jcf.2023.05.004_bib0028","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. an official american thoracic society and european respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2023.05.004_bib0029","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2730","article-title":"Socioeconomic status, smoke exposure, and health outcomes in young children with cystic fibrosis","volume":"139","author":"Ong","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jcf.2023.05.004_bib0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcf.2020.11.008","article-title":"Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation","volume":"20","author":"Guimbellot","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.jcf.2023.05.004_bib0031","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2023.05.004_bib0032","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03148-21","article-title":"Combining ivacaftor and intensive antibiotics achieves limited clearance of cystic fibrosis infections","volume":"12","author":"Durfey","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.jcf.2023.05.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102262","article-title":"The changing landscape of the cystic fibrosis lung environment: from the perspective of Pseudomonas aeruginosa","volume":"65","author":"Greenwald","year":"2022","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"10.1016\/j.jcf.2023.05.004_bib0034","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323001340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T08:18:37Z","timestamp":1756714717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323001340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1569199323001340"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.05.004","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Pseudomonas aeruginosa infection stage with lung function trajectory in children with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}